Join the 'Glaucoma' group to help and get support from people like you.

Glaucoma Blog

Glaucoma Can Affect Babies, Too

Posted 2 Jul 2014 by Drugs.com

WEDNESDAY, July 2, 2014 – When Olivia Goree noticed something just "wasn't right" about her 6-week-old son's eyes, she trusted her instincts and took him to the doctor. What she never expected was the diagnosis: glaucoma. "I was really surprised," recalled Goree, who said she had only ever heard of the vision-robbing disease affecting older adults. And that's probably how most people think of glaucoma, since it's largely diagnosed in people older than 60. But rarely, the disease can strike infants and children. Glaucoma refers to a group of eye diseases in which fluid builds up in the eye, creating pressure that damages the optic nerve and leads to vision loss. In some cases, a baby will be born with glaucoma as part of a syndrome of birth defects, explained Dr. Robert Barnes, an ophthalmologist at Loyola University Medical Center in Maywood, Ill., who treated Goree's son, Christian. ... Read more

Related support groups: Glaucoma

Eye 'Training' May Help Restore Some Vision Lost to Glaucoma

Posted 22 Apr 2014 by Drugs.com

TUESDAY, April 22, 2014 – A new computerized eye-training program could upend the long-held belief that glaucoma-related vision loss is irreversible, a small study suggests. Daily "vision workouts" restored a significant degree of sight to a group of glaucoma patients by taking advantage of the brain's talent for learning new tricks, researchers said. "Glaucoma is a disease that slowly, over the course of years, damages the retina and optic nerve in the eye," said study lead author Bernhard Sabel, director of the Institute of Medical Psychology at the Otto-von-Guericke University of Magdeburg in Germany. "When tissue is damaged, vision impairments are the consequence," he added. Until now, vision loss was considered permanent. "All that could be done was to halt further progression," he said. Generally, vision loss from glaucoma begins with peripheral or side vision, leading to what ... Read more

Related support groups: Glaucoma

Glaucoma Drug May Help Reverse Obesity-Related Vision Loss

Posted 22 Apr 2014 by Drugs.com

TUESDAY, April 22, 2014 – A drug used to treat glaucoma eye disease can also help people with vision loss linked to obesity, a new study reveals. Researchers examined the effectiveness of the inexpensive drug, called acetazolamide (Diamox), in women and men with the condition known as "idiopathic intracranial hypertension." According to the researchers, the disorder primarily affects overweight women of reproductive age, and 5 percent to 10 percent of women with it suffer disabling vision loss. This study included 161 women and four men with idiopathic intracranial hypertension and mild vision loss. The investigators found that adding acetazolamide to a weight-loss plan featuring calorie reduction, lowered salt intake and exercise boosted vision improvement in these patients. Specifically, the vision of those who took the drug improved twice as much after six months compared to those ... Read more

Related support groups: Obesity, Glaucoma, Diamox, Acetazolamide, Diamox Sequels

Postmenopausal Estrogen Therapy Tied to Lower Glaucoma Risk

Posted 30 Jan 2014 by Drugs.com

THURSDAY, Jan. 30, 2014 – Women who take estrogen-only hormone-replacement therapy to relieve menopausal symptoms might also be reducing their risk for a common form of the eye disease glaucoma, according to new research. "Ours is one of the first ... studies to find estrogen-containing hormone-replacement therapy was associated with a reduction in glaucoma risk," said study researcher Dr. Joshua Stein, an assistant professor of ophthalmology at the University of Michigan. Other studies, however, have come up with conflicting results, Stein said. In his study, he looked at insurance-claims data for women aged 50 and older who were enrolled in a managed care plan for at least four years. The women visited an eye care provider at least twice from 2001 to 2009. He evaluated information on more than 152,000 women, about 60,000 of whom had at least one prescription for estrogen-only ... Read more

Related support groups: Estradiol, Premarin, Glaucoma, Estrace, Postmenopausal Symptoms, Ethinyl Estradiol, Vivelle, Vagifem, Climara, Estrace Vaginal Cream, Vivelle-Dot, Estring, Estradiol Patch, Evamist, Premarin Vaginal, Enjuvia, Cenestin, Minivelle, Femring, Estraderm

Risk of Glaucoma Blindness Drops by Half: Study

Posted 24 Jan 2014 by Drugs.com

FRIDAY, Jan. 24, 2014 – Better eye care seems to have brightened the long-term outlook for people with glaucoma. The likelihood of blindness in glaucoma patients 20 years after diagnosis has fallen by at least half in the last generation, according to a new study. Researchers analyzed the medical records of all the people 40 and older in Olmsted County, Minn., who were diagnosed with the eye disease between 1981 and 2000. The investigators compared these people to patients diagnosed with glaucoma between 1965 and 1980. The incidence of glaucoma did not change, but the risk of going blind in at least one eye fell from about 26 percent in the earlier group of patients to less than 14 percent in the newer group. The researchers also found that the annual incidence of glaucoma-caused blindness dropped by more than half. The results were published online in the January issue of the journal ... Read more

Related support groups: Glaucoma

Your Contact Lens Might Someday Dispense Eye Drugs

Posted 9 Dec 2013 by Drugs.com

MONDAY, Dec. 9, 2013 – Contact lenses that deliver glaucoma medication over long periods are getting closer to reality, say researchers working with laboratory animals. In their study, the lenses delivered the glaucoma drug latanoprost (brand name Xalatan) continuously to animals for a month. It's hoped that some day such lenses will replace eye drops now used to treat the eye disease, the researchers said. "In general, eye drops are an inefficient method of drug delivery that has notoriously poor patient adherence," study lead author Dr. Joseph Ciolino, a cornea specialist at the Massachusetts Eye and Ear Infirmary, said in an infirmary news release. "This contact lens design can potentially be used as a treatment for glaucoma and as a platform for other [eye] drug delivery applications." Glaucoma is the leading cause of irreversible blindness worldwide. The lenses, which appeared ... Read more

Related support groups: Glaucoma

'The Pill' Tied to Raised Risk of Glaucoma

Posted 18 Nov 2013 by Drugs.com

MONDAY, Nov. 18, 2013 – Taking birth control pills for more than three years may increase a woman's risk of developing the eye disease glaucoma, a new study suggests. The findings are from an investigation involving more than 3,400 women aged 40 and older who took part in the U.S. National Health and Nutrition Examination Survey between 2005 and 2008. "At this point, women who have taken oral contraceptives for three or more years should be screened for glaucoma and followed closely by an ophthalmologist, especially if they have any other existing risk factors," said lead researcher Dr. Shan Lin, professor of clinical ophthalmology at the University of California, San Francisco. Women who took birth control pills for longer than three years were twice as likely to have been diagnosed with glaucoma, according to the study. The findings were presented Monday at the annual meeting of the ... Read more

Related support groups: Birth Control, Contraception, Plan B, Sprintec, Mirena, Implanon, Provera, NuvaRing, Tri-Sprintec, Yasmin, Depo-Provera, Ortho Tri-Cyclen, Loestrin 24 Fe, Lutera, TriNessa, Microgestin Fe 1/20, Ortho Evra, Mononessa, Ortho Tri-Cyclen Lo, Nexplanon

Sleep Apnea May Be Linked to Glaucoma, Study Says

Posted 16 Aug 2013 by Drugs.com

FRIDAY, Aug. 16 – People with sleep apnea are at increased risk for glaucoma and should be screened for the eye disease, a new study suggests. Researchers examined the medical records of more than 1,000 people 40 and older who were diagnosed with sleep apnea between 2001 and 2004, and compared them to a "control" group of more than 6,000 people without sleep apnea. Those with sleep apnea were 1.67 times more likely to develop the most common type of glaucoma (open-angle glaucoma) within five years of their sleep apnea diagnosis than those in the control group, according to the study, published in the August issue of the journal Ophthalmology. Glaucoma is the second-leading cause of blindness worldwide. While previous research has found that glaucoma is more common among people with sleep apnea, this study concluded that sleep apnea is an independent risk factor for open-angle glaucoma. ... Read more

Related support groups: Glaucoma, Sleep Apnea

Glaucoma Screening Not for Everyone: Experts

Posted 9 Jul 2013 by Drugs.com

TUESDAY, July 9 – Not enough evidence exists to recommend that primary-care doctors screen for glaucoma in adults who do not have vision problems, according to the U.S. Preventive Services Task Force. Although there are many new treatments for glaucoma, the task force concluded there is too little evidence available to determine how best to screen for and diagnose glaucoma in adults with no signs or symptoms of vision problems. Also, there is not enough evidence to show that screening reduces the likelihood of vision loss and blindness. "Glaucoma is a serious disease that can cause vision problems and blindness in millions of Americans," task force co-vice chairman Dr. Albert Siu said in a news release. "Unfortunately, we don't have enough evidence to know how best to screen for the disease and who would benefit from screening in the primary-care setting." The task force's review of ... Read more

Related support groups: Glaucoma

Common Glaucoma Drug May Cause Droopy Eyelids, Study Finds

Posted 24 May 2013 by Drugs.com

FRIDAY, May 24 – Drugs commonly used to treat glaucoma may cause droopy eyelids and other side effects that can interfere with vision, according to a new study. The drugs, known as prostaglandin analogues (PGAs), which are used to reduce eye pressure, have already been shown to cause blurred vision, dryness and changes in eye color, the researchers said, suggesting that the new findings could lead to labeling changes for PGAs. Doctors should be conservative when prescribing these drugs, the researchers added, particularly as a preventive measure for patients at risk for glaucoma. "The loss of periorbital fat was previously described by us in a small series of unilateral PGA users," senior study author Dr. Louis Pasquale, director of the glaucoma service at the Massachusetts Eye and Ear Infirmary, said in an infirmary news release. "Those observations did ultimately lead to a change in ... Read more

Related support groups: Glaucoma, Xalatan, Lumigan, Travatan, Latanoprost, Travatan Z, Travoprost, Bimatoprost

Glucosamine Supplements Tied to Risk of Eye Condition

Posted 23 May 2013 by Drugs.com

THURSDAY, May 23 – Glucosamine supplements that millions of Americans take to help treat hip and knee osteoarthritis may have an unexpected side effect: They may increase risk for developing glaucoma, a small new study of older adults suggests. Glaucoma occurs when there is an increase of intraocular pressure (IOP) or pressure inside the eye. Left untreated, glaucoma is one of the leading causes of blindness. In the new study of 17 people, whose average age was 76 years, 11 participants had their eye pressure measured before, during and after taking glucosamine supplements. The other six had their eye pressure measured while and after they took the supplements. Overall, pressure inside the eye was higher when participants were taking glucosamine, but did return to normal after they stopped taking these supplements, the study showed. "This study shows a reversible effect of these ... Read more

Related support groups: Glaucoma, Glucosamine, Optiflex-G, Genicin

Alcon Announces FDA Approval of Simbrinza Suspension, a New Beta Blocker-Free, Fixed-Combination Therapy for Glaucoma Patients

Posted 23 Apr 2013 by Drugs.com

Basel, April 19, 2013 – Alcon, the global leader in eye care and a division of Novartis, announces US FDA approval for Simbrinza Suspension, indicated for the reduction of elevated intraocular pressure (IOP) in patients with primary open-angle glaucoma or ocular hypertension.4 Elevated IOP is the only modifiable risk factor for glaucoma. Glaucoma is a group of eye diseases that lead to progressive damage of the optic nerve5 and can result in gradual, irreversible loss of vision, and eventually blindness, if left untreated.6 Glaucoma affects more than 2.2 million Americans7 and is the second-leading cause of preventable blindness worldwide.8 Simbrinza is a fixed-dose combination medication that offers a wide range of treatment possibilities due to its strong efficacy and ability to decrease elevated IOP by 21- 35%.1,2,3 In addition, it is the only available, fixed-dose combination ... Read more

Related support groups: Glaucoma, Glaucoma (Open Angle), Intraocular Hypertension, Brimonidine, Brinzolamide

Best Glaucoma Treatments Still a Puzzle, Task Force Reports

Posted 18 Feb 2013 by Drugs.com

MONDAY, Feb. 18 – Drugs and surgery can lower the hallmark inner-eye pressure characteristic of glaucoma – the second-leading cause of blindness in the United States. But research still hasn't identified the best ways to prevent significant vision loss and improve patient satisfaction, according to a prominent government medical group. The U.S. Preventive Services Task Force (USPSTF) reviewed dozens of studies and collective reviews on open-angle glaucoma, which accounts for about 90 percent of all cases, concluding there's inadequate evidence to directly compare the effectiveness of medical, surgical or laser treatments. The task force, comprised of 16 independent experts in prevention and evidence-based medicine, also said it couldn't determine whether glaucoma screening for adults without previous vision problems prevents blindness or enhances long-term health. "We know that ... Read more

Related support groups: Glaucoma, Glaucoma (Open Angle), Glaucoma/Intraocular Hypertension

U.S. Glaucoma Cases Jump 22 Percent Over Decade: Report

Posted 13 Dec 2012 by Drugs.com

THURSDAY, Dec. 13 – The prevalence of glaucoma in the United States is 22 percent higher than it was 10 years ago, a new report reveals. Researchers from Prevent Blindness America and the U.S. National Eye Institute reported that more than 2.7 million Americans aged 40 and older are affected by this eye disease, which can damage the optic nerve and gradually lead to blindness. Symptoms for glaucoma develop slowly, so the condition is also known as the "sneak thief of sight." The researchers pointed out in a joint news release that more than 50 percent of those who have glaucoma are not even aware of it. To increase awareness and educate people about glaucoma, Prevent Blindness America joined forces with other leading vision and eye health groups to declare January as National Glaucoma Awareness Month. Among the people at greatest risk for glaucoma are those who are older and have a ... Read more

Related support groups: Glaucoma, Glaucoma (Open Angle), Glaucoma/Intraocular Hypertension, Glaucoma (Narrow Angle)

'Micro-Stents' May Hold Potential to Treat Glaucoma

Posted 13 Nov 2012 by Drugs.com

TUESDAY, Nov. 13 – Tiny devices that allow fluid to drain from the eye could reduce the dangerously high pressure in the eyes of glaucoma patients. These "micro-stents" – including one that's newly available and others that are under development – come with caveats. They may not protect the eyes from glaucoma in the long term, and it's unclear if they're effective when not used in conjunction with cataract surgery. Still, research continues. This week, scientists released a preliminary study of one type of micro-stent that says it allowed most patients to avoid having to take eye drops to control their eye pressure. Dr. Thomas Samuelson, a glaucoma specialist with Minnesota Eye Consultants, was the study's medical monitor. Dr. James Salz, a spokesman for the American Academy of Ophthalmology and clinical professor of ophthalmology at the University of Southern California, said that ... Read more

Related support groups: Glaucoma

Page 1 2 3 Next

Ask a Question

Further Information

Related Condition Support Groups

Glaucoma (Open Angle), Glaucoma/Intraocular Hypertension, Glaucoma (Narrow Angle), Glaucoma with Pupillary Block, Eye Conditions

Related Drug Support Groups

Diamox, nadolol, Combigan, acetazolamide, Corgard, Diamox Sequels, methazolamide, Daranide, Phospholine Iodide, view more... Isopto Carbachol, Ocusert, echothiophate iodide, dichlorphenamide, Pilopine-HS, Humorsol Ocumeter, Piloptic-3, Akarpine, Piloptic-2, Piloptic-4, Piloptic-6, E-Pilo-4, E-Pilo-6, P6E1, E-Pilo-2, Mitosol, P4E1, Piloptic-1, P1E1, P2E1, P3E1, E-Pilo-1, Glauctabs, brimonidine/timolol, mitomycin ophthalmic, Isopto Carpine, epinephrine/pilocarpine, demecarium bromide, apraclonidine, carbachol, Pilocar, Miostat, Pilagan with C Cap, Ocu-Carpine, Piloptic-1/2, Adsorbocarpine, Neptazane, Carboptic, Iopidine, Pilostat